• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Critical-care pain observation tool demonstrates reliability for critically ill pediatric patients

byPaary BalakumarandAlex Chan
April 26, 2025
in Emergency, Pediatrics
Reading Time: 2 mins read
Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study
Share on FacebookShare on Twitter

1. The Critical-Care Pain Observation Tool (CPOT) showed strong correlations with other validated pain observation tools in pediatric patients

Evidence Rating Level: 3 (Average) 

The Critical-Care Pain Observation Tool (CPOT), a behavioral pain assessment scale validated in adults, was evaluated for use in critically ill pediatric patients, particularly in mixed-age intensive care units where a single, versatile tool is beneficial. This prospective observational study included 91 children (165 assessments) aged 0–18 years in an open pediatric ICU. CPOT scores were compared with the FLACC scale and an observational Visual Analog Scale (VAS obs) to assess criterion and construct validity. The CPOT showed strong correlations with FLACC (ρ = 0.84) and VAS obs (ρ = 0.87), with especially high agreement among intubated and non-intubated patients. A CPOT cutoff score of ≥3 demonstrated excellent diagnostic performance (AUC = 0.98, sensitivity 100%, specificity 96.7%). CPOT scores significantly increased during painful medical interventions (p < 0.01), supporting its responsiveness to procedural pain. Inter-rater reliability was high (weighted κ = 0.89), confirming consistency across observers. While further validation is needed in larger, more diverse populations and among patients with neurological impairments, these findings suggest that CPOT is a valid, reliable, and practical tool for assessing pain in critically ill pediatric patients and may facilitate standardized pain management across age groups and care settings.

Click to read the study in PLOSONE

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

2 Minute Medicine Rewind September 14, 2026

Tags: anesthesiologypainpediatric critical carepediatricsPICU
Previous Post

Upper extremity pain associated with poor functional recovery post-stroke

Next Post

Motivational interviewing not effective in reducing rehospitalisation and improving patient activation among patients with respiratory failure

RelatedReports

Imaging and Intervention

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

September 18, 2026
Chronic Disease

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

September 17, 2026
Weekly Rewinds

2 Minute Medicine Rewind September 14, 2026

September 14, 2026
Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Next Post
Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Motivational interviewing not effective in reducing rehospitalisation and improving patient activation among patients with respiratory failure

Quick Take: Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG)

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

Significant reduction in prostate screening rates after revised guidelines

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
  • 2 Minute Medicine Rewind September 28, 2026
  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.